Platinum-based Chemotherapy with or without Thoracic Radiation Therapy in Patients with Unresectable Thymic Carcinoma

Y. Nakamura
2000 Japanese Journal of Clinical Oncology  
Thymic carcinoma is a rare mediastinal neoplasm with poor prognosis. Although the clinical benefit of chemotherapy for thymic carcinoma is controversial, cisplatin-based chemotherapy with or without radiation therapy is ordinarily adopted in advanced cases. We evaluated the clinical outcome of platinum-based chemotherapy with or without radiation therapy in unresectable thymic carcinoma patients. Methods: Ten patients with unresectable thymic carcinoma were treated with platinum-based
more » ... num-based chemotherapy with or without radiation therapy in the National Cancer Center Hospital between 1989 and 1998. We reviewed the histological type, treatment, response and survival of these patients. Results: Four of the 10 patients responded to chemotherapy and both the median progression-free survival period and the median response duration were 6.0 months. The median survival time was 11.0 months. There was no relationship between histological classification and prognosis. Conclusions: Platinum-based chemotherapy with or without thoracic radiation is, regardless of tumor histology, marginally effective in advanced thymic carcinoma patients, giving only a modest tumor response rate and short response duration and survival.
doi:10.1093/jjco/hyd108 pmid:11095135 fatcat:uj3u6d4verh3hmq34hijhxqy6y